Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (81-90 of 394) with videos related to

Pageof 40
Sort By:
Hepatology (Baltimore, Md.)|October 17, 2015
No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mLThomas R O'Brien, Jordan J Feld, Shyam Kottilil, et al.
CMAJ Open|August 31, 2017
Model-based projection of health and economic effects of screening for hepatitis C in CanadaWilliam W L Wong, Aysegul Erman, Jordan J Feld, et al.
Biophysical Journal|September 8, 2016
Absolute Ligand Discrimination by Dimeric Signaling ReceptorsSepehr Fathi, Chitra R Nayak, Jordan J Feld, et al.
Hepatology (Baltimore, Md.)|January 28, 2014
How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observationsJonathan A Dranoff, Jordan J Feld, Elise G Lavoie, et al.
Journal of Hepatology|May 13, 2015
Immigration and viral hepatitisSuraj Sharma, Manuel Carballo, Jordan J Feld, et al.
Journal of Materials Chemistry. B|April 9, 2020
Arresting the time-dependent H<sub>2</sub>O<sub>2</sub> mediated synthesis of gold nanoparticles for analytical detection and preparative chemistryPierangelo Gobbo, Mia J Biondi, Jordan J Feld, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patientsWendy A Henderson, Ravi Shankar, Jordan J Feld, et al.
Clinics in Liver Disease|October 1, 2021
Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic ResultsArif Sarowar, Grishma Hirode, Harry L A Janssen, et al.
ACS Nano|April 2, 2016
Clinical Validation of Quantum Dot Barcode Diagnostic TechnologyJisung Kim, Mia J Biondi, Jordan J Feld, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2019
Review article: clinical pharmacology of current and investigational hepatitis B virus therapiesElise J Smolders, David M Burger, Jordan J Feld, et al.
Pageof 40

Showing results (81-90 of 394) with videos related to

Sort By:
Pageof 40
Hepatology (Baltimore, Md.)|October 17, 2015
No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mLThomas R O'Brien, Jordan J Feld, Shyam Kottilil, et al.
CMAJ Open|August 31, 2017
Model-based projection of health and economic effects of screening for hepatitis C in CanadaWilliam W L Wong, Aysegul Erman, Jordan J Feld, et al.
Biophysical Journal|September 8, 2016
Absolute Ligand Discrimination by Dimeric Signaling ReceptorsSepehr Fathi, Chitra R Nayak, Jordan J Feld, et al.
Hepatology (Baltimore, Md.)|January 28, 2014
How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observationsJonathan A Dranoff, Jordan J Feld, Elise G Lavoie, et al.
Journal of Hepatology|May 13, 2015
Immigration and viral hepatitisSuraj Sharma, Manuel Carballo, Jordan J Feld, et al.
Journal of Materials Chemistry. B|April 9, 2020
Arresting the time-dependent H<sub>2</sub>O<sub>2</sub> mediated synthesis of gold nanoparticles for analytical detection and preparative chemistryPierangelo Gobbo, Mia J Biondi, Jordan J Feld, et al.
The Pediatric Infectious Disease Journal|July 14, 2009
Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patientsWendy A Henderson, Ravi Shankar, Jordan J Feld, et al.
Clinics in Liver Disease|October 1, 2021
Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic ResultsArif Sarowar, Grishma Hirode, Harry L A Janssen, et al.
ACS Nano|April 2, 2016
Clinical Validation of Quantum Dot Barcode Diagnostic TechnologyJisung Kim, Mia J Biondi, Jordan J Feld, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2019
Review article: clinical pharmacology of current and investigational hepatitis B virus therapiesElise J Smolders, David M Burger, Jordan J Feld, et al.
Pageof 40